Литература
1. Gordon A.M., Charles J., Wolf S.L. Methods of constraint- induced movement therapy for children with hemiplegic cerebral palsy: development of a child-friendly intervention for improving upper-extremity function. Arch. Phys. Med. Rehabil. 2005; 86(4): 837-844.
2. Eliasson A.C., Krumlinde-Sundholm L., Shaw K., Wang C. Effects of constraint-induced movement therapy in young children with hemiplegic cerebral palsy: an adapted model. Dev. Med. Child. Neurol. 2005; 47(4): 266-275.
3. Naylor C.E., Bower E. Modified constraint-induced movement therapy for young children with hemiplegic cerebral palsy: a pilot study. Dev. Med. Child. Neurol. 2005; 47(6): 365- 369.
4. Charles J.R., Wolf S.L., Schneider J.A., Gordon A.M. Efficacy of a child-friendly form of constraint-induced movement therapy in hemiplegic cerebral palsy: a randomized control trial. Dev. Med. Child. Neurol. 2006; 48(8): 635-642.
5. Sutcliffe T.L., Gaetz W.C., Logan W.J. et al. Cortical reorganization after modified constraint-induced movement therapy in pediatric hemiplegic cerebral palsy. J. Child. Neurol. 2007; 22(11): 1281-1287.
6. Hoare B., Imms C., Carey L., Wasiak J. Constraintinduced movement therapy in the treatment of the upper limb in children with hemiplegic cerebral palsy: a Cochrane systematic review. Clin. Rehabil. 2007; 21(8): 675-685.
7. Hoare B.J., Wasiak J., Imms C., Carey L. Constraintinduced movement therapy in the treatment of the upper limb in children with hemiplegic cerebral palsy. Cochrane Database Syst. Rev. 2007; (2): CD004149.
8. Hoare B.J., Imms C., Rawicki H.B., Carey L. Modified constraint-induced movement therapy or bimanual occupational therapy following injection of botulinum toxin-A to improve bimanual performance in young children with hemiplegic cerebral palsy: a randomised controlled trial methods paper. BMC Neurol. 2010; 10: 58.
9. Hoare B., Imms C., Villanueva E. et al. Intensive therapy following upper limb botulinum toxin A injection in young children with unilateral cerebral palsy: a randomized trial. Dev. Med. Child. Neurol. 2013; 55(3): 238-247.
10. Cope S.M., Forst H.C., Bibis D., Liu X.C. Modified constraint-induced movement therapy for a 12-month-old child with hemiplegia: a case report. Am. J. Occup. Ther. 2008; 62(4): 430-437.
11. Wallen M., Ziviani J., Herbert R. et al. Modified constraint- induced therapy for children with hemiplegic cerebral palsy: a feasibility study. Dev. Neurorehabil. 2008; 11(2): 124- 133.
12. Smania N., Aglioti S.M., Cosentino A. et al. A modified constraint-induced movement therapy (CIT) program improves paretic arm use and function in children with cerebral palsy. Eur. J. Phys. Rehabil. Med. 2009; 45(4): 493-500.
13. Park E.S., Rha D.W., Lee J.D. et al. The short-term effects of combined modified constraint-induced movement therapy and botulinum toxin injection for children with spastic hemiplegic cerebral palsy. Neuropediatrics. 2009; 40(6): 269-274.
14. Coker P., Karakostas T., Dodds C., Hsiang S. Gait characteristics of children with hemiplegic cerebral palsy before and after modified constraint-induced movement therapy. Disabil Rehabil. 2010; 32(5): 402-408.
15. Aarts P.B., Jongerius P.H., Geerdink Y.A. et al. Effectiveness of modified constraint-induced movement therapy in children with unilateral spastic cerebral palsy: a randomized controlled trial. Neurorehabil Neural. Repair. 2010; 24(6): 509-518.
16. Aarts P.B., Jongerius P.H., Geerdink Y.A. et al. Modified Constraint-Induced Movement Therapy combined with Bimanual Training (mCIMT-BiT) in children with unilateral spastic cerebral palsy: how are improvements in arm-hand use established? Res. Dev. Disabil. 2011; 32(1): 271-279.
17. Aarts P.B., van Hartingsveldt M., Anderson P.G. et al. The Pirate group intervention protocol: description and a case report of a modified constraint-induced movement therapy combined with bimanual training for young children with unilateral spastic cerebral palsy. Occup. Ther. Int. 2012; 19(2): 76-87.
18. Choudhary A., Gulati S., Kabra M. et al. Efficacy of modified constraint induced movement therapy in improving upper limb function in children with hemiplegic cerebral palsy: a randomized controlled trial. Brain Dev. 2013; 35(9): 870-876. doi: pii: S0387-7604(12)00277-X. 10.1016/j.braindev. 2012.11.001.
19. Rostami H.R., Malamiri R.A. Effect of treatment environment on modified constraint-induced movement therapy results in children with spastic hemiplegic cerebral palsy: a randomized controlled trial. Disabil. Rehabil. 2012; 34(1): 40-44.
20. Deppe W., Thuemmler K., Fleischer J. et al. Modified constraint-induced movement therapy versus intensive bimanual training for children with hemiplegia – a randomized controlled trial. Clin. Rehabil. 2013; 27(10): 909-920.
21. Geerdink Y., Aarts P., Geurts A.C. Motor learning curve and long-term effectiveness of modified constraint-induced movement therapy in children with unilateral cerebral palsy: a randomized controlled trial. Res. Dev. Disabil. 2013; 34(3): 923-931.
22. DeLuca S.C., Echols K., Law C.R., Ramey S.L. Intensive pediatric constraint-induced therapy for children with cerebral palsy: randomized, controlled, crossover trial. J. Child. Neurol. 2006; 21(11): 931-938.
23. Hsin Y.J., Chen F.C., Lin K.C. et al. Efficacy of constraint- induced therapy on functional performance and healthrelated quality of life for children with cerebral palsy: a randomized controlled trial. J. Child. Neurol. 2012; 27(8): 992-999.
24. DeLuca S.C., Trucks M.R., Wallace D.A., Ramey S.L. Practice-based evidence from a clinical cohort that received pediatric constraint-induced therapy. J. Pediatr. Rehabil. Med. 2017; 10(1): 37-46. doi: 10.3233/PRM-170409.
25. Bartley J., Carroll J.E. Stem cell therapy for cerebral palsy. Expert. Opin. Biol. Ther. 2003; 3(4): 541-549.
26. Селедцов В.И., Кафанова М.Ю., Рабинович С.С., Повещенко О.В., Кащенко Э.А., Фельде М.А., Самарин Д.М., Селедцова Г.В., Козлов В.А. Клеточная терапия детского церебрального паралича. Клеточные технологии в биологии и медицине. 2005; 2: 84-88.
27. Seledtsov V.I., Kafanova M.Y., Rabinovich S.S. et al. Cell therapy of cerebral palsy. Bull. Exp. Biol. Med. 2005; 139(4): 499-503.
28. Goldman S.A., Schanz S., Windrem M.S. Stem cellbased strategies for treating pediatric disorders of myelin. Hum. Mol. Genet. 2008; (R1): R76-83.
29. Mehta T., Feroz A., Thakkar U. et al. Subarachnoid placement of stem cells in neurological disorders. Transplant. Proc. 2008; 40(4): 1145-1147.
30. Harris D.T. Cord blood stem cells: a review of potential neurological applications. Stem. Cell. Rev. 2008; 4(4): 269-274.
31. Harris D.T. Non-haematological uses of cord blood stem cells. Br. J. Haemat. 2009; 147(2): 177-184. 32. Ul Hassan A., Hassan G., Rasool Z. Role of stem cells in treatment of neurological disorder. Int. J. Health. Sci. (Qassim). 2009; 3(2): 227-233.
33. Patoine B. NerveCenter: media focus on ‘miracle cure’ for cerebral palsy pits science vs. hype. Ann. Neurol. 2009; 66(4): A9-11.
34. Patoine B. NerveCenter: Stem cells surge forward to clinical trials, but fears remain. Ann. Neurol. 2009; 65(5): A9- A11.
35. Mankikar S.D. Stem cells: a new paradigm in medical therapeutics. J. Long. Term. Eff. Med. Implants. 2010; 20(3): 219-250.
36. Bell E., Wallace T., Chouinard I. et al. Responding to requests of families for unproven interventions in neurodevelopmental disorders: hyperbaric oxygen “treatment” and stem cell “therapy” in cerebral palsy. Dev. Disabil. Res. Rev. 2011; 17(1): 19-26.
37. Carroll J.E., Mays R.W. Update on stem cell therapy for cerebral palsy. Expert. Opin. Biol. Ther. 2011; 11(4): 463-471.
38. Bennet L., Tan S., Van den Heuij L. et al. Cell therapy for neonatal hypoxia-ischemia and cerebral palsy. Ann. Neurol. 2012; 71(5): 589-600.
39. Li M., Yu A., Zhang F. et al. Treatment of one case of cerebral palsy combined with posterior visual pathway injury using autologous bone marrow mesenchymal stem cells. J. Transl. Med. 2012; 10: 100. 40. Purandare C., Shitole D.G., Belle V. et al. Therapeutic potential of autologous stem cell transplantation for cerebral palsy. Case. Rep. Transplant. 2012; 2012: 825289.
41. Luan Z., Liu W., Qu S. et al. Effects of neural progenitor cell transplantation in children with severe cerebral palsy. Cell. Transplant. 2012. 21(Suppl 1): S91-98.
42. Chen G., Wang Y., Xu Z. et al. Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy. J. Transl. Med. 2013; 11: 21.
43. Jensen A., Hamelmann E. First autologous cell therapy of cerebral palsy caused by hypoxic-ischemic brain damage in a child after cardiac arrest-individual treatment with cord blood. Case. Rep. Transplant. 2013; 2013: 951827.
44. Min K., Song J., Kang J.Y. et al. Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial. Stem. Cells. 2013; 31(3): 581-591.
45. Wang L., Ji H., Zhou J. et al. Therapeutic potential of umbilical cord mesenchymal stromal cells transplantation for cerebral palsy: a case report. Case. Rep. Transplant. 2013; 2013: 146347.
46. Ruff C.A., Faulkner S.D., Fehlings M.G. The potential for stem cell therapies to have an impact on cerebral palsy: opportunities and limitations. Dev. Med. Child. Neurol. 2013; 55(8): 689-697.
47. Пичугина Е. Запчасти для человека. Лечение ДЦП: результаты обнадеживают. Московский комсомолец. 2013; 146(107): 17.
48. Bloom R., Przekop A., Sanger T.D. Prolonged electromyogram biofeedback improves upper extremity function in children with cerebral palsy. J. Child. Neurol. 2010; 25(12): 1480-1484.
49. Cheng H.Y., Ju Y.Y., Chen C.L. et al. Managing lower extremity muscle tone and function in children with cerebral palsy via eight-week repetitive passive knee movement intervention. Res. Dev. Disabil. 2013; 34(1): 554-561.
50. Prosser L.A., Curatalo L.A., Alter K.E., Damiano D.L. Acceptability and potential effectiveness of a foot drop stimulator in children and adolescents with cerebral palsy. Dev. Med. Child. Neurol. 2012; 54(11): 1044-1049.